Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WDR35 divergent transcript (WDR35-DT) is a non-coding RNA gene uncharacterized in the literature; it does not encode a protein and currently lacks evidence for involvement in biological functions, disease mechanisms, druggability, or utility as a biomarker. It should not be conflated with WDR35 (WD repeat domain 35), a protein involved in intraflagellar transport and ciliogenesis. Search results do not provide evidence that WDR35-DT is a protein, receptor, or therapeutic target. In contrast, the protein-coding gene WDR35 is involved in ciliary function and related diseases, but that is an entirely different entity. If you intended to refer to WDR35 rather than WDR35-DT, please clarify, as only WDR35 (the protein) has established disease associations and molecular functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WDR35 divergent transcript (WDR35-DT).